new glp 1 drug retatrutide Promises Big Weight Loss, but Safety Remains a Question Back in 2023 we saw

Soft tissue facial changes following massive weight loss secondary to medical and surgical bariatric interventions: a systematic review

Pinto, an obesity and family medicine doctor at Johns Hopkins Medicine in Baltimore, who wasnt involved in the research

Discuss how the impairment impacts social or occupational functioning, such as absences from work or inability to care for children

Research-only supply (21+) Products are supplied strictly for laboratory research use

When considering what to eat on Mounjaro or other GLP-1 therapies, focus should shift toward smaller, nutrient-dense portions that prioritise lean proteins and high-fibre vegetables